(2) Yasuhiko Tabata, Masatsugu Mochizuki, Toshio Hayashi, and Akio Nakajima
Synthesis and properties of copolypeptide membranes composed of N-hydroxyethyl
glutamine as one component.
Rept. Progr. Polym. Phys., Japan, 25, 683-686 (1982)
(3) Toshio Hayashi, Kouhei Kugo, Yasuhiko Tabata, and Akio Nakajima
Structure and physical properties of tri-block copolymer membranes containing
poly(γ-methyl L-glutamate as one component.
Rept. Progr. Polym. Phys., Japan, 25, 687-690 (1982)
(4) Kouhei Kugo, Yasuhiko Tabata, Toshio Hayashi, and Akio Nakajima,
Studies on membrane surfaces of A-B-A tri-block copolymers consisting of
poly(ε-N-benzyl-oxycarbonyl L-lysine) as the A component an polybutadiene
as the B component.
Polymer J., 14, 401-415 (1982)
(5) Yasuhiko Tabata, Toshio Hayashi, and Akio Nakajima
Synthesis and properties of copolypeptide membranes composed of N-hydroxyhexyl
glutamine as one component.
Rept. Progr. Polym. Phys., Japan, 26, 487-490 (1983)
(6) Yasuhiko Tabata, Toshio Hayashi, and Akio Nakajima
Biodegradation of a poly(α-amino acid) in vitro.I. Biodegradation of poly(N-hydroxyalkyl-L-glutamine)
by papain.
Rept. Progr. Polym. Phys., Japan, 26, 587-590 (1983)
(7) Yasuhiko Tabata, Toshio Hayashi, and Akio Nakajima
Biodegradation of a poly(α-amino acid) in vitro.II. Biodegradation of copolymers
consisting of N-hydroxyalkyl-L-glutamine and L-glutamic acid by papain.
Rept. Progr. Polym. Phys., Japan, 26, 591-594 (1983)
(8) Yasuhiko Tabata, Toshio Hayashi, and Akio Nakajima
Biodegradation of a poly(α-amino acid) in vitro.III. Biodegradation of
copolymers consisting of N-hydroxyalkyl-D,L-glutamine and L-glutamic acid
by papain.
Rept. Progr. Polym. Phys., Japan, 27, 614-620 (1984)
(9) Yasuhiko Tabata, Toshio Hayashi, and Akio Nakajima
Biodegradation of a poly(α-amino acid) in vitro.IV. Biodegradation of random
copolypeptides consisting of L-glutamic acid and L-alanine,L-leucine or
L-valine by papain.
Rept. Progr. Polym. Phys., Japan, 27, 621-624 (1984)
(10) Toshio Hayashi, Yasuhiko Tabata, and Akio Nakajima
Biodegradation of a poly(α-amino acid) in vitro.
Polymer J., 17, 463-471 (1985)
(11) Toshio Hayashi, Kazuo Takeshima, Yasuhiko Tabata, and Akio Nakajima
Preparation and properties of A-B-A tri-block copolymer membranes consisting
of N-hydroxyethyl- L-glutamine as the A component and L-leucine as the B
component.
Polymer J., 17, 1149-1157 (1985)
(12) 田畑泰彦，筏 義人
分解吸収性微粒子によるマクロファ?ジの活性化
化学 (40) 1, 1-3 (1985)
(13) 田畑泰彦，筏 義人
生体分解性微粒子によるマクロファージの抗腫瘍活性化
第86回ポバール会記録 57-66(1985)
(14) 和田良一，田畑泰彦，玄 丞烋，筏 義人
ポリ乳酸マイクロカプセルからの抗癌剤の徐放
第87回ポバール会記録 1-10(1985)
(15) 田畑泰彦
免疫療法への応用
ドラッグデリバリ?システム ：監修 嘉悦 勲 CMC p.278-282 (1986)
(16) Yoshito Ikada and Yasuhiko Tabata
Phagocytosis of bioactive microspheres.
J.Bioactive Compatible Polymers 1, 32-46 (1986)
(17) 田畑泰彦、筏 義人,
マクロファージによる微粒子貪食に及ぼす粒子径と表面の影響
Annual Report of the Research Institute for Chemical Fibers, 43, 69-76
(1986)
(18) Satoshi Watanabe, Jyunn Isobe, Yasuhiko Shimizu, Yasuhiko Tabata, and
Yoshito Ikada
Microencapsulated multi-enzyme system applied for bioreactor and artificial
organs.
Jpn. J. Artif. Organs, 15(1), 243-248 (1986)
(19) Yasuhiko Tabata, Shrikant V.Lonikar, Fumitaka Horii, and Yoshito Ikada
Immobilization of collagen onto polymer surfaces having hydroxyl groups.
Biomaterials, 7, 234-238 (1986)
(20) Yasuhiko Tabata and Yoshito Ikada
Macrophage activation through phagocytosis of muramyl dipeptide encapsulated
in gelatinmicrosphere.
J. Pharm. Parmacol., 39, 698-704 (1987)
(21) Yasuhiko Tabata and Yoshito Ikada
Activation of macrophage in vitro to acquire antitumor activity by a muramyl
dipeptide derivative encapsulated in microspheres composed of lactide copolymer.
J. Controlled Release, 6, 189-204 (1987)
(22) Yasuhiko Tabata, Kazuko Uno, Yoshito Ikada, and Shigeru Muramatsu
Potentiation of antitumor activity of macrophages by recombinant interferon
alpha A/D contained in gelatin microspheres. Jpn.
J. Cancer Res., 79, 636-646 (1988)
(23) Yasuhiko Tabata, Kazuko Uno, Yoshito Ikada, and Shigeru Muramatsu
Activation of antitumor function of macrophages by gelatin microspheres
containing recombinant interferon alpha A/D.
Bulletin de L'Institut Pasteur de Kyoto, 2, 49-59 (1988)
(24) Yasuhiko Tabata and Yoshito Ikada
Macrophage activation for antitumor function by a muramyl dipeptide derivative
encapsulated in polylactide microspheres. Advances in Biomaterials, C.de
Putter etal. Eds., Elsevier SciencePublishers, B.V. Amsterdam, Vol. 8, p.263-268
(1988)
(25) Ryoichi Wada, Yasuhiko Tabata, Suong-Hyu Hyon, and Yoshito Ikada
Preparation of poly(lactic acid) microspheres containing anti-cancer drugs.
Bull. Inst. Chem. Res., Kyoto Univ., 68(3), 241-250 (1988)
(26) Yasuhiko Tabata and Yoshito Ikada
Macrophage phagocytosis of biodegradable microspheres composed of L-lactic
acid/glycolic acid homo- and copolymers.
J. Biomed. Mater. Res., 22, 837-858 (1988)
(27) Yasuhiko Tabata and Yoshito Ikada
Effect of the size and surface charge of polymer microspheres on their
phagocytosis by macrophage.
Biomaterials, 9, 356-362 (1988)
(28) 田畑泰彦
医薬品を中心にバイオマテリアル国際会議報告
PharmTech Japan, 4(8), 26-28 (1988)
(29) Yasuhiko Tabata and Yoshito Ikada
Effect of surface wettability of microspheres on phagocytosis.
J. colloid Interface Sci., 127(1), 132-140 (1989)
(30) Yasuhiko Tabata and Yoshito Ikada
Synthesis of gelatin microspheres containing interferon.
Pharm. Res., 6(5), 422-427 (1989)
(31) 田畑泰彦，筏 義人
マクロファージの活性化に与える免疫賦活剤含有ポリ乳酸微粒子の性質の影響
生体材料，7(2), 79-86 (1989)
(32) Yasuhiko Tabata and Yoshito Ikada
Protein precoating of polylactide microspheres containing a lipophilic
immunopotentiator for enhancement of macrophage phagocytosis and activation.
Pharm. Res., 6(4), 296-301 (1989)
(33) Hiroshi Yoshikawa, Yasuhiko Tabata, Yasuhiro Nakano, Kanji Takada, Shozou
Muranishi,
Ryoichi Wada, Suong-Hyu Hyon, and Yoshito Ikada Targeted and sustained
delivery of aclarbicin to lymphatics by lactic acid oligomer microspheres
in rat.
Chem, Pharm. Bull., 37(3), 802-805 (1989)
(34) Yasuhiko Tabata, Kazuko Uno, Shigeru Muramatsu, and Yoshito Ikada
In vivo effects of recombinant interferon alpha A/D incorporated in gelatin
microspheres on murine tumor cell growth.
Jpn. J. Cancer Res., 80, 387-393 (1989)
(35) Yasuhiko Tabata and Yoshito Ikada
Macrophage activation for antitumor function by muramyl dipeptide-protein
conjugates.
J. Pharm. Pharmacol., 42, 13-19 (1990)
(36) Yin-Chao Tseng, Yasuhiko Tabata, Suong-Hyu Hyon, and Yoshito Ikada
In vitro toxicity test of 2-cyanoacrylate polymers by cell culture method.
J. Biomed. Mater. Res., 24, 1355-1367 (1990)
(37) Takashi Ushida, Tetsuya Tateishi, Yasuhiko Tabata, and Yoshito Ikada
Phagocytosis of glatin-precoated hydroxyapatite particles by macrophages.
p. 33-40, Bioceramics vol.2, 1990.
(38) 立石哲也、牛田多加志、青木秀希、赤尾 勝、筏 義人、田畑泰彦、中村正章、武田昭二
細胞培養法による生体適合性の評価試験法に関する研究
通産省機械技術研究、44(5), 166-172 (1990)
(39) Takashi Ushida, Tetsuya Tateishi, Yasuhiko Tabata, and Yoshito Ikada
Phagocytosis in vitro of hydroxyapatite and polystyrene particles
by macrophages.Handbook of Bioactive Ceramics, Volume II, Takao Yamamura
Ed., p. 301-304,CRC Press, 1990.
(40) Yasuhiko Tabata and Yoshito Ikada
Phagocytosis of polymer microspheres by macrophages.
Advances in Polymer Sciences, 94, 107-141 (1990)
(41) Yasuhiko Tabata and Yoshito Ikada,
Phagocytosis of polymeric microspheres.
In "High Performance Biomaterials", M.Szycher Ed., p621-646, Technomic
Publishing Co. Inc., Lancaster, Basel (1991)
(42) Yasuhiko Tabata and Yoshito Ikada
Drug delivery systems for antitumor activation of macrophages.
Critical Reviews in Therapeutic Drug Carrier Systems, 7(2) 121-148 (1991)
(43) 田畑泰彦
生体内分解吸収性高分子微粒子を用いたマクロファージの抗腫瘍活性化
生体材料、9(2), 81-93 (1991)
(44) 田畑泰彦、筏 義人
薬物のマクロファージへのターゲティング
細胞工学、10(2), 110-117 (1991)
(45) Yasuhiko Tabata and Yoshito Ikada
Phogocytosis of polymeric microspheres. in "high Performance Biomaterials" Edited
by M. Szycher,
p.621-646, Technomic Publishing Co. Inc., Lncaster (1991)
(46) 井上一知、森 博之、前谷俊三、田畑泰彦、筏 義人
Bio-artificial Pancreas: Mesh-reinforced polyvinyl alcohol tube使用の有効性に関する検討
人工臓器、20(1), 199-202 (1991)
(47) Yasuhiko Tabata and Yoshito Ikada
Augmentation of antitumor activity of macrophages through chemical modification
with gelatin.
in "Polymers and Biomaterials" Edited by H. Feng, Y Han, and L.
Huang,
p. 317-323, Elsevier Science Publishers B.V. 1991
(48) Yasuhiko Tabata, Kazuko Uno, Tetsuji Yamaoka, Yoshito Ikada, and Shigeru
Muramatsu,
Effects of recombinant α-interferon-gelatin conjugate on in vivo murine
tumor cell growth.
Cancer Res., 51, 5532-5538 (1991)
(49) Yasuhiko Tabata, Yoshihiro Takebayashi, Torataro Ueda, and Yoshito Ikada
Release of proteins from lactic acid oligomers
in "Advances in New Drug Development" edited by B.-K. Kim, C.-K.
Kim, and Y.N. Ham, p.708-719 The pharmaceutical society of Korea 1991
(50) 赤見坂聖士、田畑泰彦、村上正裕、吉川広之、高田寛治、村西昌三、和田良一、筏 義人
アクラルビシン含有乳酸オリゴマーマイクロスフェアのリンパ指向性と持続性- 乳酸オリゴマーの分子量およびマイクロスフェアのサイズの影響 -
Drug Delivery System, 6(1), 35-39 (1991)
(51) 山岡哲二，田畑泰彦，筏 義人
体内に注射された高分子の血中寿命とその行くえ
第99回ポバール会記録 77-85(1991)
(52) Janet Tamada, Yasuhiko Tabata, and Robert Langer,
The development of polyanhydride for drug delivery applications.
J. Biomater. Sci., Polym. Eds., 3, 315-353 (1992)
(53) Osamu Ike, Yasuhiko Shimizu, Ryoichi Wada, S.-H. Hyon, Yasuhiko Tabata,
and Yoshito Ikada
Controlled cisplatin delivery system using poly(D,L-lactic acid).
Biomaterials, 13, 230-234 (1992)
(54) 藤原一央，藤原芳茂，早川克己，中村達雄，清水慶彦，竹林禎浩，田畑泰彦，筏 義人
ポリL-乳酸マイクロスフェアーによる経カテーテル的肝動脈塞栓効果の検討
人工臓器 21(3), 1071-1075(1992)
(55) Shinetsu Kadowaki, Yasuhiko Tabata, Kenkichi Sugimoto, Yoko Tsurumaki,
Yoshito Ikada, Jun Fujita, Kazuhiro J. Mori
Application of poly(L-lactic acid) particles for the suppression of
genetic resistance to bone marrow allografts by reticuloendothelial system-blockage.
Biomedical and Pharmaceutical Therapeutics, 47, 387-391 (1993)
(56) Yasuhiko Tabata, Yoshihiro Takebayashi, Torataro Ueda, and Yoshito Ikada,
A formulation method using D,L-lactic acid oligomer for protein release
with reduced initial burst.
J. Controlled Release, 23, 55-64 (1993)
(57) Yasuhiko Tabata, Sunitha Gutta, and Robert Langer
Controlled delivery systems for proteins using polyanhydride microspheres.
Pharm. Res., 10, 487-496 (1993)
(58) Yasuhiko Tabata and Yoshito Ikada
Physicochemical properties of gelatin microcapsules prepared by a lipophilic
crosslinking agent.
Biomedical Materials Research in the Far-East (I) Xingdong Zhang and Yoshito
Ikada eds., p50-54 (1993).
(59) Tetsuji Yamaoka, Yasuhiko Tabata, and Yoshito Ikada
Blood clearance and organ distribution of intravenously administered polystyrene
microspheres with different sizes.
J. Bioactive Compt. Polymer, 8, 220-235 (1993)
(60) Tetsuji Yamaoka, Yasuhiko Tabata, and Yoshito Ikada
Body distribution profile of polysaccharides after intravenous administration.
Drug Delivery, 1, 75-82 (1993)
(61) Yasuhiko Tabata, Ryusuke Nakaoka, and Yoshito Ikada
Modification of body distribution of superoxide dismutase through poly(ethylene
glycol)conjugation.
Biomedical Materials Research in the Far-East (I) Xingdong Zhang and Yoshito
Ikada eds., p137-140 (1993).
(62) Yasuhiko Tabata and Robert Langer
Polyanhydride microspheres that display near-constant release of water-soluble
model drug compounds.
Pharm. Res., 10, 391-399 (1993)
(63) Yasuhiko Tabata, Kazuko Uno, Yoshito Ikada, and Shigeru Muramatsu
Suppressive effect of recombinant TNF-gelatin conjugate on murine tumour
cell growth in-vivo.
J. Pharm. Pharmacol., 45, 303-308 (1993)
(64) Yasuhiko Tabata, Kazuko Uno, Yoshito Ikada, Tsunataro Kishida, and Shigeru
Muramatsu,
Potentiation of in vivo antitumor effects of recombinant interleukin-1-αby
gelatin conjugation.
Jpn. J. Cancer Res., 84, 681-686 (1993)
(65) Y. Tabata, S. Hijikata, Y. Ikada
In vivo neovascularization effect of biodegradable hydrogels containing
basic fibroblast growth factor.
Controlled Release Society, Inc. (1993)
(66) Yasuhiko Tabata and Yoshito Ikada
Targeting of muramyl peptide to macrophages by gelatin conjugation to enhance
their in vivo antitumor activity.
J. Controlled Release, 27, 79-88 (1993)
(67) 田畑泰彦
診断・医薬用高分子材料：化学ハンドブック、鈴木周一、向山光昭編集、
p.713-720 (1993)
(68) 田畑泰彦，井上美晴，筏 義人
PVAを用いたタンパク質包含微粒子の作製
第102回ポバール会記録 1-10(1993)
(69) 田畑泰彦
有機廃液の焼却とのつき合い：環境保全、京都大学環境保全センター、
p.60-62 (1993)
(70) Yasuhiko Tabata, Achim Goepferich, Ruxandra Gref, Yoshiharu Minamitake,
Lisa Shieh, Maria Jose Alonso, and Robert Langer
Formulation of biodegradable polymers for delivery of Protein and Peptides.
(J.Cleland and R. Langer Eds.) ACS Symposium Series, p 242-277 (1994)
(71) Ichiro Fuke, Toshio Hayashi, Yasuhiko Tabata, and Yoshito Ikada
Synthesis of poly(ethylene glycol) derivatives with different branching
and their use for protein modification.
J. Controlled Release, 30(1), 27-34 (1994)
(72) Tetsuji Yamaoka, Yasuhiko Tabata, and Yoshito Ikada
Body distribution of intravenously administered gelatin with different
molecular weights.
J. Controlled Release, 31, 1-8 (1994)
(73) Tetsuji Yamaoka, Yasuhiko Tabata, and Yoshito Ikada
Accumulation of Poly(vinyl alcohol) at inflammatory site.
ACS Symposium Series No 545, Polymeric Drugs and Drug Administration, R.O.Ottenbritte
Ed., 163-171 (1994)
(74) Tetsuji Yamaoka, Yasuhiko Tabata, and Yoshito Ikada
Distribution and tissue uptake of poly(ethylene glycol) with different
molecular weights after intravenous administration to mice.
J. Pharm. Sci., 83, 601-606 (1994)
(75) Tetsuji Yamaoka, Yasuhiko Tabata, Masatoshi Kuroda, and Yoshito Ikada
Body distribution of dextran derivatives with electric charges after intravenous
administration.
Int. J. Pharm., 113, 149-157 (1994)
(76) Yasuhiko Tabata, Abraham Domb, and Robert Langer
Polyanhydride injectable granules provide controlled release of water-soluble
drugs with reduced initial burst.
J. Pharm. Sci., 83, 5-11 (1994)
(77) Takeshi Moridera, Yuichiro Ogura, Nagahisa Yoshimura, Shoji Kuriyama,Yoshihito
Honda, Yasuhiko Tabata, and Yoshito Ikada
Feasibility of drug targeting to the retinal pigment epithelium with biodegradable
microspheres.
Current Eye Research, 13, 171-176 (1994)
(78) Hideya Kimura, Yasuhiko Tabata, Yuichiro Ogura, Takeshi Moridera, Yoshihito
Honda,and Yoshito Ikada
In vitro phagocytosis of polylactide microspheres by retinal pigment epithelial
cells and intracellular drug release.
Current Eye Research, 13, 353-360 (1994)
(79) Lisa Shieh, Janet Tamada, Yasuhiko Tabata, Abraham Domb, and Robert
Langer
Drug release from a new family of biodegradable polyanhydrides.
J. Controlled Release, 29, 73-82 (1994)
(80) 筏 義人，田畑泰彦
タンパク質含有高分子ミクロスフィアの調整とその抗体産生補助能
Rep. Chem. Mat.R&D Found, 9, 89-93(1994)
(81) Yasuhiko Tabata, Shigeki Hijikata, and Yoshito Ikada
Enhanced vascularization and tissue granulation by basic fibroblast growth
factor impregnated in gelatin hydrogels.
J. Controlled Release, 31, 189-199 (1994)
(82) Yasuhiko Tabata and Yoshito Ikada
Potentiated in vivo biological activity of basic fibroblast growth factor
by incorporation intopolymer hydrogel microsphere.
4th Japan International SAMPE Symposium,p577-582 (1995)
(83) Hideya Kimura, Taiji Sakamoto, Christine Spee, David R. Hinton, Yuichiro
Ogura, Yasuhiko Tabata, Yoshito Ikada, and Stephen J. Ryan
A new model of experimental subretinal neovascularization in the rabbits,
Current Eye Research, 36(10), 2110-2119 (1995)
(84) Tetsuji Yamaoka, Yasuhiko Tabata, Yoshito Ikada, and Hitoshi Yamaoka
Radiolabeling of polystyrene by gamma-ray in the presence of Na125I solution.
Radiation Phys. Chem., 46, 71-75 (1995)
(85) Tetsuji Yamaoka, Yasuhiko Tabata, and Yoshito Ikada
Comparison of body distribution of poly(vinyl alcohol) with other water-soluble
polymers after intravenous administration.
J. Pharm. Pharmacol., 47, 479-486 (1995)
(86) Tetsuji Yamaoka, Yasuhiko Tabata, and Yoshito Ikada
Fate of water-soluble polymers administered via different routes.
J. Pharm. Sci., 84, 349-354 (1995)
(87) Yasuhiko Tabata, C.C.Mylonas, Robert Langer, and Yonathan Zohar
Preparation and evaluation of polyanhydride microspheres containing gonadotropin-releasinghormone
(GnRH) for inducing ovulation and spermination in fish.
J. Controlled Release, 35, 23-34 (1995)
(88) Ryusuke Nakaoka, Yasuhiko Tabata, and Yoshito Ikada
Potentiality of gelatin microspheres as immunological adjuvant.
Vaccine, 13(7), 653-661 (1995)
(89) Ryusuke Nakaoka, Yasuhiko Tabata, and Yoshito Ikada
Enhanced antibody production through sustained antigen release from biodegradable
granules.
J. Controlled Release, 37, 215-224 (1995)
(90) 清谷哲也、大谷友人、田畑泰彦、筏 義人、北河康之、中村達雄、清水慶彦
新しいゼラチン系接着剤の止血効果の検討
人工臓器、24(1), 111-114 (1995)
(91) Y. Tabata, Y. Ikada
Enhanced macrophage activation for antitumor function by muramyl dipeptide
chemically modified with gelatin of different
Molecular weights. Proceed. Intern Symp. Control. Rel. Bioact. Mater,.,
22(1995)
(92) Yuto Otani, Yasuhiko Tabata, and Yoshito Ikada,
A biological glue composed of gelatin and poly(l-glutamic acid). Biomedical
Materials
Research in the Far- East (II) Xingdong Zhang and Yoshito Ikada eds., p49-52
(1996).
(93) Yuto Otani, Yasuhiko Tabata, and Yoshito Ikada,
A new biological glue from gelatin and poly(L-glutamic acid).
J. Biomed. Mater. Res., 31, 157-166 (1996)
(94) Yuto Otani, Yasuhiko Tabata, and Yoshito Ikada,
Adhesion of soft tissue by gelatin-polyanion hydrogels,
J. Adhesion, 59, 197-205 (1996)
(95) Yuto Otani, Yasuhiko Tabata, and Yoshito Ikada
A rapidly curable biological glue composed of gelatin and poly(L-glutamic
acid).
Biomaterials, 17, 1387-1391 (1996)
(96) Yasuhiko Tabata, Yoshiharu Inoue, and Yoshito Ikada
Induction of plasma IgG antibody through oral administration of biodegradable
poly(lactic acid) microspheres containing antigen.
Biomedical Materials Research in the Far- East (II) Xingdong Zhang and
Yoshito Ikada eds., p31-35 (1996).
(97) 田畑泰彦、筏 義人
抗原を含有した生体内分解吸収性高分子微粒子のパイエル板からの取り込みとその抗体産生の粒子径依存性
消化器と免疫、33, 202-206 (1996)
(98) Ryusuke Nakaoka, Yasuhiko Tabata, Yoshiharu Inoue, and Yoshito Ikada,
Size effect on the antibody production induced by biodegradable microspheres
containing antigen.
Vaccine, 14, 1251-1256 (1996)
(99) Kazumi Itoi, Yasuhiko Shimizu, Yasuhiko Tabata, M.Kuwabara, Mitoki Kyo,
S.-H. Hyon,and Yoshito Ikada,
In vivo antitumor effects of copoly(glycolic/lactic) acid microspheres
containing CDDP
J. Controlled Release, 42, 175-184 (1996)
(100) Ryusuke Nakaoka, Yasuhiko Tabata, and Yoshito Ikada
Antibody production by administration of biodegradable granules incorporating
antigen through different injection routes.
J. Controlled Release, 40, 11-21 (1996)
(101) Yasuhiko Tabata, Ryusuke Nakaoka, and Yoshito Ikada
Production of interleukin 1 from macrophages incubated with poly(DL-lactic
acid) granules containing ovalbumin.
Biomaterials, 17, 2253-2258 (1996)
(102) Ryusuke Nakaoka, Yasuhiko Tabata, and Yoshito Ikada
Adjuvant effect of biodegradable poly(DL-lactic acid) granules capable
for antigen release following intraperitoneal injection.
Vaccine, 14, 1671-1676 (1996)
(103) Yoshiyuki Murakami, Yasuhiko Tabata, and Yoshito Ikada
Effect of the molecular weight of water-soluble polymers on accumulation
at an infllammatory site following intravenous injection.
Drug Delivery, 3, 231-238 (1996)
(104) Keli Xi, Yasuhiko Tabata, Kazuko Uno, Miwa Yoshimoto, Tsunataro Kishida,
Yoshihiro Sokawa, and Yoshito Ikada
Liver targeting of interferon through pullulan conjugation.
Pharmaceutical Research. 13, 1846-1850 (1996)
(105) Yasuhiko Tabata, Yoshiharu Inoue, and Yoshito Ikada, Size effect on
systemic and mucosal immune responses induced by oral administration of biodegradable
microspheres.
Vaccine, 14, 1677-1685 (1996)
(106) 田畑泰彦、筏 義人, 山本雅哉、山田圭介、宮本 享、菊池晴彦
吸収性高分子を用いた骨組織の再生
Annual Report of the Research Institute for Chemical Fibers, 53, 49-57
(1996)
(107) Shigeki Hijikata, Yasuhiko Tabata, and Yoshito Ikada
Preparation and neovascularization effect of basic fibroblast growth factor
(bFGF)-incorporated in gelatin microspheres.
Biomedical Materials Research in the Far- East (II) Xingdong Zhang and
Yoshito Ikada eds., p36-37 (1996).
(108) Kazuo Yamamoto, Susumu Miyamoto, Izumi Nagata, Haruhiko Kikuchi,
Yasuhiko Tabata, and Yoshito Ikada
Angiogenesis in rat cerebral cortex by basic fibroblast growth factor.
Biomedical Materials Research in the Far- East (II) Xingdong Zhang and
Yoshito Ikada eds., p43-44 (1996).
(109) Md. Muniruzzaman, Yasuhiko Tabata, and Yoshito Ikada,
Protein permeation through biodegradable gelatin hydrogels.
Biomedical Materials Research in the Far- East (II) Xingdong Zhang and
Yoshito Ikada eds., p49-50 (1996).
(110) Shinetsu Kadowaki, Yasuhiko Tabata, Yoko Tsurumaki, Yoshito Ikada,
Jun Fujita, Kazuhiro J. Mori, Suppression effect of genetic resistance to
bone marrow allografts by reticuloendothelial system-blockage through biodegradable
microspheres.
Biomedical and Pharmaceutical Therapeutics, 50, 235-239 (1996)
(111) Yasuhiko Tabata and Yoshito Ikada
Biodegradable gelatin microspheres for drug delivery to macrophages
in "Microspheres/Microcapsules - Characterization and Pharmaceutical
Application"Eds. by S.Cohen and H.Bernstein, Marcel Dekker Inc., p401-423
(1996)
(112) 田畑泰彦、筏 義人
ドラッグデリバリーシステムの粘膜免疫への応用、
特集 粘膜免疫の基礎と応用、最新医学、51(4), 66-71 (1996)
(113) 田畑泰彦、筏 義人
徐放性マイクロカプセルの粘膜ワクチンへの応用、
別冊・医学のあゆみ 生体防御の最前線、202-206 (1996)
(114) 田畑泰彦、筏 義人
ターゲティング療法の進歩、
綜合臨床、46(9), 2259-2266 (1997)
(115) 田畑泰彦、筏 義人
抗がん剤としての水溶性フラーレン、
BIO INDUSTRY、14(7), 1-8 (1997)
(116) Atsuhiro Nagano, Yasuhiko Tabata, and Yoshito Ikada
Growth factor release from biodegradable gelatin hydrogels for tissue engineering.
Biomedical Materials Research in the Far- East (III) Xingdong Zhang and
Yoshito Ikada eds., p4-5 (1997).
(117) Keisuke Yamada, Yasuhiko Tabata, Kazuo Yamamoto, Susumu Miyamoto, Izumi
Nagata, Haruhiko Kikuchi, and Yoshito Ikada
Potential efficacy of basic fibroblast growth factor incorporated in biodegradablehydrogels
for skull bone regeneration.
J. Neurosurg., 85, 871-875 (1997)
(118) Hey Won Kang, Yasuhiko Tabata, and Yoshito Ikada,
Preparation of injectable gelatin hydrogels for tissue engineering.
Biomedical Materials Research in the Far- East (III) Xingdong Zhang and
Yoshito Ikada eds., p9-12 (1997).
(119) Md. Muniruzzaman, Yasuhiko Tabata, and Yoshito Ikada,
Polyion complexation of basic fibroblast growth factor.
Biomedical Materials Research in the Far- East (III) Xingdong Zhang and
Yoshito Ikada eds., p36-39 (1997).
(120) Md. Muniruzzaman, Yasuhiko Tabata, and Yoshito Ikada,
Protein interaction with gelatin hydrogels for tissue engineering.
Porous Materials for Tissue Engineering, D.-M. Liu and V. Dixit eds., Trans
Tech. Publication, 250, p.89-96 (1997).
(121) Yasuhiko Tabata, Yoshiyuki Murakami, and Yoshito Ikada,
Size effect of water-soluble polymers and microgels on tumor accumulation.
Biomedical Materials Research in the Far- East (III) Xingdong Zhang and
Yoshito Ikada eds., p212-215 (1997).
(122) Yasuhiko Tabata, Kazuko Uno, Shigeru Muramatsu, Tsunataro Kishida,
and Yoshito Ikada
Chemical modification of recombinant interleukin 2 by gelatin augments
its antitumor potency in the murine model.
PasKen Journal, 9, 67-85 (1997)
(123) Yoshiyuki Murakami, Yasuhiko Tabata, and Yoshito Ikada
Tumor accumulation of poly(ethylene glycol) with different molecular weightsafter
intravenous injection.
Drug Delivery, 4, 23-31 (1997)
(124) Yasuhiko Tabata, Toshiyuki Kawai, Yoshiyuki Murakami, and Yoshito Ikada
Electric charge influence of dextran derivatives on their tumor accumulation
after intravenous injection.
Drug Delivery, 4, 213-221 (1997)
(125) Ryusuke Nakaoka, Yasuhiko Tabata, Tetsuji Yamaoka, and Yoshito Ikada
Prolongation of the serum half-life period of superoxide dismutase bypoly(ethylene
glycol) modification.
J. Controlled Release, 46, 253-261 (1997)
(126) 田畑泰彦、筏 義人
フラーレンと生体薬理作用、特集フラーレンとナノチューブの科学
Science University of Tokyo Bulletin、12, 40-43 (1997)
(127) 田畑泰彦、筏 義人
フラーレンの医学利用における今後の展望、がん増殖抑制効果を中心に
Isotope News、516, 2-5 (1997)
(128) 田畑泰彦、筏 義人
C60の抗がん作用、
ニューダイヤモンド、13(3), 36-37 (1997)
(129) 田畑泰彦，村上義幸，筏 義人
ポリエチレングリコールにて修飾したフラーレン(C60)の抗がん作用
第111回ポバール会記録 51-59(1997)
(130) Yasuhiko Tabata, Yoshiyuki Murakami, and Yoshito Ikada
Antitumor effect of polyethylene glycol-modified fullerene.
J. Fullerene Sci. and Tech., 5(5), 989-1007 (1997)
(131) Yasuhiko Tabata, Yoshiyuki Murakami, and Yoshito Ikada
Photodynamic effect of polyethylene glycol-modified fullerene on tumor.
Jpn. J. Cancer Res., 88, 1108-1116 (1997)